Table of Content

1 INTRODUCTION 70
1.1 STUDY OBJECTIVES 70
1.2 MARKET DEFINITION AND SCOPE 70
1.2.1 INCLUSIONS AND EXCLUSIONS 71
1.2.2 MARKETS COVERED 72
1.2.3 YEARS CONSIDERED 73
1.3 CURRENCY CONSIDERED 73
1.4 STAKEHOLDERS 73
1.5 RESEARCH LIMITATIONS 74
1.6 SUMMARY OF CHANGES 74
1.7 RECESSION IMPACT 75
2 RESEARCH METHODOLOGY 76
2.1 RESEARCH DATA 76
FIGURE 1 RESEARCH DESIGN 76
2.1.1 SECONDARY DATA 77
2.1.2 PRIMARY DATA 78
FIGURE 2 PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES 78
2.2 MARKET SIZE ESTIMATION 79
FIGURE 3 PROTEOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 79
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 80
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022 80
2.2.1 INSIGHTS FROM PRIMARIES 82
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 82
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, SOFTWARE & SERVICE, AND END USER) 82
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 82
2.3 GROWTH RATE ASSUMPTIONS 83
FIGURE 8 PROTEOMICS MARKET: CAGR PROJECTIONS, 2023–2028 84
FIGURE 9 PROTEOMICS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 84
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 85
FIGURE 10 DATA TRIANGULATION METHODOLOGY 85
2.5 STUDY ASSUMPTIONS 86
2.6 RISK ANALYSIS 86
2.7 IMPACT OF ECONOMIC RECESSION ON PROTEOMICS MARKET 86
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2027 (% GROWTH) 87
TABLE 2 US HEALTH EXPENDITURE, 2019–2027 (USD MILLION) 87
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 87
3 EXECUTIVE SUMMARY 88
FIGURE 11 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 88
FIGURE 12 PROTEOMICS MARKET, BY REAGENT, 2023 VS. 2028 (USD MILLION) 89
FIGURE 13 PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2023 VS. 2028 (USD MILLION) 90
FIGURE 14 PROTEOMICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 90
FIGURE 15 PROTEOMICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 91
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF PROTEOMICS MARKET 92
4 PREMIUM INSIGHTS 93
4.1 OVERVIEW OF PROTEOMICS MARKET 93
FIGURE 17 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET 93
4.2 NORTH AMERICA: PROTEOMICS MARKET SHARE, BY APPLICATION AND COUNTRY (2022) 94
FIGURE 18 CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PROTEOMICS MARKET IN 2022 94
4.3 ELECTROPHORESIS MARKET SHARE, BY TYPE, 2023 VS. 2028 (USD MILLION) 95
FIGURE 19 GEL ELECTROPHORESIS TO DOMINATE MARKET IN 2028 95
4.4 PROTEOMICS MARKET SHARE, BY END USER (2022) 95
FIGURE 20 PHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 95
4.5 PROTEOMICS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 96
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN PROTEOMICS MARKET DURING STUDY PERIOD 96
5 MARKET OVERVIEW 97
5.1 INTRODUCTION 97
5.2 MARKET DYNAMICS 97
FIGURE 22 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 97
TABLE 4 PROTEOMICS MARKET: IMPACT ANALYSIS 98
5.2.1 DRIVERS 98
5.2.1.1 Increasing demand for personalized medicines for clinical practices 98
FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2022 99
5.2.1.2 Rising incidences of chronic diseases among geriatric population 100
5.2.1.3 Increased investments in research and greater adoption of proteomics in drug discovery 100
FIGURE 24 GLOBAL SPENDING ON PHARMACEUTICAL R&D, 2015–2028 (USD BILLION) 101
5.2.1.4 Technological advancements in proteomics 101
5.2.2 RESTRAINTS 102
5.2.2.1 High costs of proteomics instruments and technologies 102
5.2.2.2 Lack of standardization in proteomics workflow among research groups 103
5.2.3 OPPORTUNITIES 103
5.2.3.1 High growth opportunities for proteomics research in emerging countries 103
5.2.3.2 Growing prominence of nano proteomics in biological processes 104
5.2.4 CHALLENGES 105
5.2.4.1 Low biomarker discovery to approval ratio in proteomics research 105
5.2.4.2 Lack of data management/handling in proteomics research 105
5.3 VALUE CHAIN ANALYSIS 106
FIGURE 25 VALUE CHAIN ANALYSIS: MANUFACTURING AND DISTRIBUTION PHASES PROVIDE MAXIMUM VALUE 106
5.4 SUPPLY CHAIN ANALYSIS 107
FIGURE 26 PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS 107
5.5 ECOSYSTEM ANALYSIS 108
FIGURE 27 ECOSYSTEM ANALYSIS: PROTEOMICS MARKET 108
TABLE 5 PROTEOMICS MARKET: ROLE IN ECOSYSTEM 109
5.6 PORTER’S FIVE FORCES ANALYSIS 109
TABLE 6 PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 109
5.6.1 THREAT OF NEW ENTRANTS 109
5.6.2 THREAT OF SUBSTITUTES 110
5.6.3 BARGAINING POWER OF SUPPLIERS 110
5.6.4 BARGAINING POWER OF BUYERS 110
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 110
5.7 PATENT ANALYSIS 111
5.8 PRICING ANALYSIS 111
TABLE 7 AVERAGE SELLING PRICE OF PROTEOMICS PRODUCTS (2022) 111
TABLE 8 PERKINELMER: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES 112
TABLE 9 MERCK: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES 112
5.9 TECHNOLOGY ANALYSIS 113
TABLE 10 COMPARISON OF MODERN PROTEOMICS ANALYSIS METHODS 113
TABLE 11 COMMONLY USED BIOINFORMATICS TOOLS IN PROTEOMICS 114
TABLE 12 TECHNOLOGIES LAUNCHED RECENTLY IN PROTEOMICS 114
5.10 REGULATORY ANALYSIS 115
5.10.1 REGULATIONS FOR PRODUCTS DEVELOPED USING PROTEOMICS TECHNIQUES 115
TABLE 13 KEY REGULATORY GUIDELINES FOR PROTEOMICS PRODUCTS 116
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117
5.11 KEY CONFERENCES AND EVENTS IN 2023 118
TABLE 17 PROTEOMICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023 118
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 119
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 119
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS 119
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS 119
5.12.2 BUYING CRITERIA 119
FIGURE 29 KEY BUYING CRITERIA FOR END USERS 119
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 120
5.14 TRADE ANALYSIS 120
5.14.1 TRADE ANALYSIS FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS 120
TABLE 19 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2017–2021 (USD MILLION) 120
5.14.2 TRADE ANALYSIS FOR DIAGNOSTICS AND LABORATORY REAGENTS 121
TABLE 20 IMPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION) 121
TABLE 21 EXPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (TONS) 121
5.14.3 TRADE ANALYSIS FOR IMMUNOASSAYS 121
TABLE 22 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2017–2021 (USD MILLION) 121
6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 122
6.1 INTRODUCTION 123
6.1.1 PRICING ANALYSIS 123
TABLE 23 AVERAGE SELLING PRICE OF PRODUCTS AND SERVICES, 2022 (USD) 123
TABLE 24 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 124
6.2 SPECTROSCOPY 124
TABLE 25 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 26 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 27 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 28 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 29 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 30 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 127
6.2.1 MASS SPECTROSCOPY 128
6.2.1.1 High specificity of mass spectroscopy to boost market 128
TABLE 31 MASS SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 32 NORTH AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 33 EUROPE: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 34 ASIA PACIFIC: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 35 LATIN AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
6.2.2 NMR SPECTROSCOPY 131
6.2.2.1 NMR experiments to evaluate physical, chemical, electronic, and structural information of proteins 131
TABLE 36 NMR SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 37 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 38 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 39 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 40 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
6.2.3 CD SPECTROSCOPY 134
6.2.3.1 CD spectroscopy to examine changes in secondary structures of protein in response to environmental conditions 134
TABLE 41 CD SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION) 135
TABLE 42 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 43 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 44 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 45 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
6.3 CHROMATOGRAPHY 137
TABLE 46 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 47 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 48 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 49 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 50 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 51 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.3.1 HPLC 141
6.3.1.1 Growing biopharmaceutical industry and increasing investments in life science research 141
TABLE 52 HPLC MARKET, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 53 NORTH AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 54 EUROPE: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 55 ASIA PACIFIC: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 56 LATIN AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
6.3.2 ION CHROMATOGRAPHY 144
6.3.2.1 Ion chromatography to be most significant chromatographic technique for separation and purification of proteins 144
TABLE 57 ION CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 58 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 59 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 60 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 61 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
6.3.3 AFFINITY CHROMATOGRAPHY 147
6.3.3.1 Affinity chromatography to quantify protein expression using isotope-coded affinity tags 147
TABLE 62 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 63 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 64 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 65 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 66 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY 150
6.3.4.1 Supercritical fluid chromatography to separate complex protein mixtures with high efficiency and speed 150
TABLE 67 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 151
TABLE 68 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 69 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 70 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 71 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
6.4 ELECTROPHORESIS 153
TABLE 72 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 73 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 74 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 75 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 76 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 77 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION) 156
6.4.1 GEL ELECTROPHORESIS 157
6.4.1.1 Increasing demand for gel electrophoresis in proteomics research and personalized medicine 157
TABLE 78 GEL ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 157
TABLE 79 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 80 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 81 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 82 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
6.4.2 CAPILLARY ELECTROPHORESIS 160
6.4.2.1 Rise in applications of capillary electrophoresis in therapeutics and drug discovery 160
TABLE 83 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 161
TABLE 84 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 85 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 86 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 87 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
6.5 PROTEIN MICROARRAYS 163
TABLE 88 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 89 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2021–2028 (USD MILLION) 164
TABLE 90 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 91 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 92 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 93 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION) 166
6.5.1 BIOCHIPS 166
TABLE 94 BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 95 BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION) 167
TABLE 96 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 97 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 98 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 99 LATIN AMERICA: BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION) 169
6.5.1.1 Lab-on-chips 169
6.5.1.1.1 Rising applications of lab-on-chips in microfabrication and nanotechnology development 169
TABLE 100 LAB-ON-CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 101 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 102 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 103 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 104 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
6.5.1.2 Protein chips 173
6.5.1.2.1 Competitive advantage over conventional protein analysis tools 173
TABLE 105 PROTEIN CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 106 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 107 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 108 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 109 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
6.5.2 MICROARRAY INSTRUMENTS 176
TABLE 110 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 111 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 177
TABLE 112 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 113 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 114 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 115 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
6.5.2.1 Integrated systems 180
6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of large numbers of proteins 180
TABLE 116 INTEGRATED SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 180
TABLE 117 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 118 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 119 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 120 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
6.5.2.2 Microarray scanners 183
6.5.2.2.1 Microarray scanners to provide high-quality analysis and cost efficiency 183
TABLE 121 MICROARRAY SCANNERS MARKET, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 122 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 123 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 124 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 125 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
6.5.2.3 Arrayers 186
6.5.2.3.1 Technological advancements to make microarray spotters ideal for large-scale arraying projects 186
TABLE 126 ARRAYERS MARKET, BY REGION, 2021–2028 (USD MILLION) 186
TABLE 127 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 128 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 129 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 130 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 188
6.6 X-RAY CRYSTALLOGRAPHY 188
6.6.1 INCREASED NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES WITH X-RAY CRYSTALLOGRAPHY TO AID MARKET 188
TABLE 131 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2021–2028 (USD MILLION) 189
TABLE 132 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 133 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 134 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 135 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 191
6.7 SURFACE PLASMON RESONANCE 191
6.7.1 ABILITY TO MEASURE BINDING AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET 191
TABLE 136 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION) 192
TABLE 137 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 138 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 139 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 140 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 194
6.8 PROTEIN FRACTIONATION 194
6.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN COMPLEX MIXTURES 194
TABLE 141 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2021–2028 (USD MILLION) 195
TABLE 142 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 143 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 144 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 145 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION) 197
6.9 OTHER TECHNOLOGIES 197
TABLE 146 PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 198
TABLE 147 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 148 EUROPE: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 149 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 150 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 200
7 PROTEOMICS MARKET, BY REAGENT 201
7.1 INTRODUCTION 202
TABLE 151 PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 202
7.2 IMMUNOASSAY REAGENTS 202
7.2.1 IMMUNOASSAY REAGENTS TO DOMINATE PROTEOMICS MARKET DURING FORECAST PERIOD 202
TABLE 152 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2021–2028 (USD MILLION) 204
TABLE 153 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 154 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 155 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 156 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 206
7.3 SPECTROSCOPY REAGENTS 206
7.3.1 INCREASED ADOPTION OF MS-BASED APPROACHES IN PROTEOMICS TO DRIVE MARKET 206
TABLE 157 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2021–2028 (USD MILLION) 207
TABLE 158 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 159 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 160 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 161 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 209
7.4 CHROMATOGRAPHY REAGENTS 209
7.4.1 INCREASING DEMAND FOR PROTEIN PURIFICATION TO AID MARKET 209
TABLE 162 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION) 210
TABLE 163 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 210
TABLE 164 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 165 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 166 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 212
7.5 PROTEIN MICROARRAY REAGENTS 212
7.5.1 INCREASED FOCUS ON ANALYZING PROTEIN INTERACTIONS TO INCREASE USE OF PROTEIN MICROARRAY REAGENTS 212
TABLE 167 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2021–2028 (USD MILLION) 213
TABLE 168 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 169 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 170 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 171 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 215
7.6 X-RAY CRYSTALLOGRAPHY REAGENTS 215
7.6.1 X-RAY CRYSTALLOGRAPHY TO BE ESSENTIAL IN PROTEIN STRUCTURE DETERMINATION 215
TABLE 172 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION) 216
TABLE 173 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 174 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 175 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 176 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 218
7.7 ELECTROPHORESIS REAGENTS 218
7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS TO PROPEL MARKET 218
TABLE 177 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2021–2028 (USD MILLION) 219
TABLE 178 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 219
TABLE 179 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 180 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 181 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 221
7.8 PROTEIN FRACTIONATION REAGENTS 221
7.8.1 INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES TO AUGMENT MARKET 221
TABLE 182 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2021–2028 (USD MILLION) 222
TABLE 183 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 222
TABLE 184 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 223
TABLE 185 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 223
TABLE 186 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 224
7.9 OTHER REAGENTS 224
TABLE 187 PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION) 225
TABLE 188 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 225
TABLE 189 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 226
TABLE 190 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 226
TABLE 191 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 227
8 PROTEOMICS MARKET, BY SERVICE & SOFTWARE 228
8.1 INTRODUCTION 229
TABLE 192 PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 229
8.2 CORE PROTEOMICS SERVICES 229
TABLE 193 PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 194 PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY REGION, 2021–2028 (USD MILLION) 230
TABLE 195 NORTH AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 231
TABLE 196 EUROPE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 231
TABLE 197 ASIA PACIFIC: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 198 LATIN AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 232
8.2.1 PROTEIN IDENTIFICATION SERVICES 232
8.2.1.1 Rising demand for molecular weight analysis to boost market growth 232
TABLE 199 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 234
TABLE 200 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 234
TABLE 201 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 235
TABLE 202 ASIA PACIFIC: PROTE



8.3.3 BIOINFORMATICS DATABASES 262
8.3.3.1 Growing need to store proteomics data and integrate other omics databases to fuel market 262
TABLE 245 BIOINFORMATICS DATABASES MARKET, BY REGION, 2021–2028 (USD MILLION) 263
TABLE 246 NORTH AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 264
TABLE 247 EUROPE: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 264
TABLE 248 ASIA PACIFIC: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 265
TABLE 249 LATIN AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 265
9 PROTEOMICS MARKET, BY APPLICATION 266
9.1 INTRODUCTION 267
TABLE 250 PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 267
9.2 CLINICAL DIAGNOSTICS 267
TABLE 251 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 252 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 269
TABLE 253 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 269
TABLE 254 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 270
TABLE 255 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 270
TABLE 256 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 271
9.2.1 CANCER 271
9.2.1.1 Increasing investments in cancer research to drive market 271
TABLE 257 CANCER MARKET, BY REGION, 2021–2028 (USD MILLION) 272
TABLE 258 NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 272
TABLE 259 EUROPE: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 273
TABLE 260 ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 273
TABLE 261 LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 274
9.2.2 INFECTIOUS DISEASES 274
9.2.2.1 Growing prevalence of infectious diseases in emerging economices to propel market 274
TABLE 262 INFECTIOUS DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION) 275
TABLE 263 NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 275
TABLE 264 EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY 2021–2028 (USD MILLION) 276
TABLE 265 ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 276
TABLE 266 LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 277
9.2.3 DIABETES 277
9.2.3.1 Rising investments in diabetes research to drive market growth 277
TABLE 267 DIABETES MARKET, BY REGION, 2021–2028 (USD MILLION) 278
TABLE 268 NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 278
TABLE 269 EUROPE: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 279
TABLE 270 ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 279
TABLE 271 LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 280
9.2.4 NEUROLOGICAL DISORDERS 280
9.2.4.1 Increasing clinical trials and research in neurological disorders to fuel market 280
TABLE 272 NEUROLOGICAL DISORDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 281
TABLE 273 NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 281
TABLE 274 EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 282
TABLE 275 ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 282
TABLE 276 LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 283
9.2.5 AUTOIMMUNE DISEASES 283
9.2.5.1 Increasing demand for proteomics in diagnosis of autoimmune diseases to boost market 283
TABLE 277 AUTOIMMUNE DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION) 284
TABLE 278 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 284
TABLE 279 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 285
TABLE 280 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 285
TABLE 281 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 286
9.2.6 CARDIOVASCULAR DISEASES 286
9.2.6.1 High burden of cardiovascular diseases globally to increase development of more reliable proteomics tools 286
TABLE 282 CARDIOVASCULAR DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION) 287
TABLE 283 NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 287
TABLE 284 EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 288
TABLE 285 ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 288
TABLE 286 LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 289
9.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS 289
TABLE 287 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 290
TABLE 288 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 290
TABLE 289 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 291
TABLE 290 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 291
TABLE 291 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 292
9.3 DRUG DISCOVERY & DEVELOPMENT 292
TABLE 292 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 293 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 293
TABLE 294 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 294
TABLE 295 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 294
TABLE 296 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 295
TABLE 297 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 295
9.3.1 TARGET DISCOVERY 296
9.3.1.1 Increasing demand for personalized medicine to support market 296
TABLE 298 TARGET DISCOVERY MARKET, BY REGION, 2021–2028 (USD MILLION) 297
TABLE 299 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 297
TABLE 300 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 298
TABLE 301 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 298
TABLE 302 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 299
9.3.2 LEAD IDENTIFICATION 299
9.3.2.1 Lead identification to be most revenue-generating process among drug discovery & development processes 299
TABLE 303 LEAD IDENTIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION) 300
TABLE 304 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 300
TABLE 305 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 301
TABLE 306 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 301
TABLE 307 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 302
9.3.3 LEAD OPTIMIZATION 302
9.3.3.1 Lead optimization to require state-of-the-art informatics systems for transparent presentation and analysis 302
TABLE 308 LEAD OPTIMIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 303
TABLE 309 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 303
TABLE 310 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 304
TABLE 311 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 304
TABLE 312 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 305
9.3.4 PRECLINICAL STUDIES 305
9.3.4.1 Preclinical studies to facilitate transparent presentation and analysis of latest data for rapid reprioritization of synthetic targets 305
TABLE 313 PRECLINICAL STUDIES MARKET, BY REGION, 2021–2028 (USD MILLION) 306
TABLE 314 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 306
TABLE 315 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 307
TABLE 316 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 307
TABLE 317 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 308
9.4 OTHER APPLICATIONS 308
TABLE 318 PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 309
TABLE 319 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 309
TABLE 320 EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 310
TABLE 321 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 310
TABLE 322 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 311
10 PROTEOMICS MARKET, BY END USER 312
10.1 INTRODUCTION 313
TABLE 323 PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 313
10.2 HOSPITALS 313
10.2.1 RISING ADOPTION OF PROTEOMICS FOR DISEASE DIAGNOSIS TO DRIVE MARKET 313
TABLE 324 PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 314
TABLE 325 NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 315
TABLE 326 EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 315
TABLE 327 ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 316
TABLE 328 LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 316
10.3 CLINICAL LABORATORIES 317
10.3.1 INCREASING OUTSOURCING OF DIAGNOSTICS TESTS BY HOSPITALS TO SUPPORT SEGMENT 317
TABLE 329 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 318
TABLE 330 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 318
TABLE 331 EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 319
TABLE 332 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 319
TABLE 333 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 320
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 320
10.4.1 RISING FOCUS ON DRUG DISCOVERY IN BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET 320
TABLE 334 PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 321
TABLE 335 NORTH AMERICA: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 321
TABLE 336 EUROPE: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 322
TABLE 337 ASIA PACIFIC: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 322
TABLE 338 LATIN AMERICA: PROTEOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 323
10.5 ACADEMIC RESEARCH LABORATORIES 323
10.5.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINES TO AUGMENT MARKET 323
TABLE 339 PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 324
TABLE 340 NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 324
TABLE 341 EUROPE: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 325
TABLE 342 ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 325
TABLE 343 LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 326
10.6 OTHER END USERS 326
TABLE 344 PROTEOMICS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 327
TABLE 345 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 327
TABLE 346 EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 328
TABLE 347 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 328
TABLE 348 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 329
11 PROTEOMICS MARKET, BY REGION 330
11.1 INTRODUCTION 331
TABLE 349 PROTEOMICS MARKET, BY REGION, 2021–2028 (USD MILLION) 331
11.2 NORTH AMERICA 332
11.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 333
FIGURE 30 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT 333
TABLE 350 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 334
TABLE 351 NORTH AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 334
TABLE 352 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 353 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 354 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 355 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 356 NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 357 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 358 NORTH AMERICA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 337
TABLE 359 NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 338
TABLE 360 NORTH AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 338
TABLE 361 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 339
TABLE 362 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 339
TABLE 363 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 364 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 365 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 341
11.2.2 US 341
11.2.2.1 US to dominate North American proteomics market during forecast period 341
TABLE 366 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 342
TABLE 367 US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 368 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 369 US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 370 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 371 US: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 344
TABLE 372 US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 345
TABLE 373 US: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 345
TABLE 374 US: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 346
TABLE 375 US: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 376 US: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 377 US: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 347
TABLE 378 US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 379 US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 380 US: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 349
11.2.3 CANADA 349
11.2.3.1 Strong infrastructure and increased availability of funding for biomedical research to support market 349
TABLE 381 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 350
TABLE 382 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 350
TABLE 383 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 384 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 385 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, 2021–2028 (USD MILLION) 352
TABLE 386 CANADA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 352
TABLE 387 CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 352
TABLE 388 CANADA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 353
TABLE 389 CANADA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 353
TABLE 390 CANADA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 391 CANADA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION) 354
TABLE 392 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 355
TABLE 393 CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 355
TABLE 394 CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 356
TABLE 395 CANADA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 356
11.3 EUROPE 357
11.3.1 EUROPE: IMPACT OF RECESSION 357
TABLE 396 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 358
TABLE 397 EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 358
TABLE 398 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 399 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 400 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 401 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 402 EUROPE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 360
TABLE 403 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 361
TABLE 404 EUROPE: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 361
TABLE 405 EUROPE: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 362
TABLE 406 EUROPE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 362
TABLE 407 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 363
TABLE 408 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 363
TABLE 409 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 364
TABLE 410 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 364
TABLE 411 EUROPE: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 365
11.3.2 GERMANY 365
11.3.2.1 Germany to be largest market for proteomics in European region during forecast period 365
TABLE 412 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 366
TABLE 413 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 366
TABLE 414 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 415 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 367
TABLE 416 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 417 GERMANY: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 418 GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368
TABLE 419 GERMANY: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 369
TABLE 420 GERMANY: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 369
TABLE 421 GERMANY: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 370
TABLE 422 GERMANY: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 370
TABLE 423 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 371
TABLE 424 GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 371
TABLE 425 GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 372
TABLE 426 GERMANY: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 372
11.3.3 UK 373
11.3.3.1 High prevalence of cancer and growth in life science industry to fuel market 373
TABLE 427 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 2021–2028 (USD MILLION) 374
TABLE 428 UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 374
TABLE 429 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 430 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 431 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 375
TABLE 432 UK: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 433 UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 376
TABLE 434 UK: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 377
TABLE 435 UK: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 377
TABLE 436 UK: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 378
TABLE 437 UK: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 378
TABLE 438 UK: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 379
TABLE 439 UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 379
TABLE 440 UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 380
TABLE 441 UK: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 380
11.3.4 FRANCE 381
11.3.4.1 Development of new proteomics-based diagnostic tools and investments in life science R&D to drive market 381
TABLE 442 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 382
TABLE 443 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 382
TABLE 444 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 445 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 383
TABLE 446 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 447 FRANCE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 448 FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 384
TABLE 449 FRANCE: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 385
TABLE 450 FRANCE: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 385
TABLE 451 FRANCE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 386
TABLE 452 FRANCE: PROTEOMICS MARKET, FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 386
TABLE 453 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 387
TABLE 454 FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 387
TABLE 455 FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 388
TABLE 456 FRANCE: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 388
11.3.5 SWITZERLAND 389
11.3.5.1 Well-established pharmaceutical & biotechnology industry and increased investments in life science R&D infrastructure to augment market 389
TABLE 457 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 390
TABLE 458 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 390
TABLE 459 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 460 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 391
TABLE 461 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 392
TABLE 462 SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 392
TABLE 463 SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 392
TABLE 464 SWITZERLAND: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 393
TABLE 465 SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 393
TABLE 466 SWITZERLAND: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 394
TABLE 467 SWITZERLAND: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 394
TABLE 468 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 395
TABLE 469 SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 395
TABLE 470 SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 396
TABLE 471 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 396
11.3.6 ITALY 397
11.3.6.1 Increase in federal grants and private funding programs to support projects on translational research 397
TABLE 472 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 397
TABLE 473 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 398
TABLE 474 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 398
TABLE 475 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 399
TABLE 476 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 399
TABLE 477 ITALY: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 399
TABLE 478 ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 400
TABLE 479 ITALY: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 400
TABLE 480 ITALY: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 401
TABLE 481 ITALY: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 401
TABLE 482 ITALY: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 402
TABLE 483 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 402
TABLE 484 ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 485 ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 403
TABLE 486 ITALY: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 404
11.3.7 SPAIN 404
11.3.7.1 Well-established network of research centers, universities, and hospitals to aid proteomics research 404
TABLE 487 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION) 405
TABLE 488 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION) 405
TABLE 489 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION) 406
TABLE 490 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION) 406
TABLE 491 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 492 SPAIN: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 493 SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 407
TABLE 494 SPAIN: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION) 408
TABLE 495 SPAIN: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION) 408
TABLE 496 SPAIN: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 497 SPAIN: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 409
TABLE 498 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 410
TABLE 499 SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 410
TABLE 500 SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION) 411
TABLE 501 SPAIN: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION) 411